table of content
1 Study Coverage
1.1 NASH Therapeutic Drugs Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global NASH Therapeutic Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global NASH Therapeutic Drugs Market Size for the Year 2017-2028
1.2.2 Global NASH Therapeutic Drugs Market Size for the Year 2017-2028
1.3 NASH Therapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States NASH Therapeutic Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of NASH Therapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 NASH Therapeutic Drugs Market Dynamics
1.4.1 NASH Therapeutic Drugs Industry Trends
1.4.2 NASH Therapeutic Drugs Market Drivers
1.4.3 NASH Therapeutic Drugs Market Challenges
1.4.4 NASH Therapeutic Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 NASH Therapeutic Drugs by Type
2.1 NASH Therapeutic Drugs Market Segment by Type
2.1.1 Vitamin E and Pioglitazone
2.1.2 Ocaliva
2.1.3 Elafibranor
2.1.4 Selonsertib and Cenicriviroc
2.2 Global NASH Therapeutic Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global NASH Therapeutic Drugs Market Size by Type (2017-2028)
2.4 United States NASH Therapeutic Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States NASH Therapeutic Drugs Market Size by Type (2017-2028)
3 NASH Therapeutic Drugs by Application
3.1 NASH Therapeutic Drugs Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Online Provider
3.1.3 Retail Pharmacy
3.2 Global NASH Therapeutic Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global NASH Therapeutic Drugs Market Size by Application (2017-2028)
3.4 United States NASH Therapeutic Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States NASH Therapeutic Drugs Market Size by Application (2017-2028)
4 Global NASH Therapeutic Drugs Competitor Landscape by Company
4.1 Global NASH Therapeutic Drugs Market Size by Company
4.1.1 Top Global NASH Therapeutic Drugs Companies Ranked by Revenue (2021)
4.1.2 Global NASH Therapeutic Drugs Revenue by Player (2017-2022)
4.2 Global NASH Therapeutic Drugs Concentration Ratio (CR)
4.2.1 NASH Therapeutic Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of NASH Therapeutic Drugs in 2021
4.2.3 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global NASH Therapeutic Drugs Headquarters, Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global NASH Therapeutic Drugs Headquarters and Area Served
4.3.2 Global NASH Therapeutic Drugs Companies Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into NASH Therapeutic Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States NASH Therapeutic Drugs Market Size by Company
4.5.1 Top NASH Therapeutic Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States NASH Therapeutic Drugs Revenue by Players (2020, 2021 & 2022)
5 Global NASH Therapeutic Drugs Market Size by Region
5.1 Global NASH Therapeutic Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global NASH Therapeutic Drugs Market Size by Region (2017-2028)
5.2.1 Global NASH Therapeutic Drugs Market Size by Region: 2017-2022
5.2.2 Global NASH Therapeutic Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America NASH Therapeutic Drugs Market Size YoY Growth 2017-2028
6.1.2 North America NASH Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific NASH Therapeutic Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe NASH Therapeutic Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe NASH Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America NASH Therapeutic Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America NASH Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa NASH Therapeutic Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa NASH Therapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Allergan Plc (Tobira)
7.1.1 Allergan Plc (Tobira) Company Details
7.1.2 Allergan Plc (Tobira) Business Overview
7.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
7.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.1.5 Allergan Plc (Tobira) Recent Development
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Details
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
7.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.2.5 Bristol Myers Squibb Recent Development
7.3 Galmed Pharmaceuticals
7.3.1 Galmed Pharmaceuticals Company Details
7.3.2 Galmed Pharmaceuticals Business Overview
7.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
7.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.3.5 Galmed Pharmaceuticals Recent Development
7.4 Genfit SA
7.4.1 Genfit SA Company Details
7.4.2 Genfit SA Business Overview
7.4.3 Genfit SA NASH Therapeutic Drugs Introduction
7.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.4.5 Genfit SA Recent Development
7.5 Gilead Sciences, Inc.
7.5.1 Gilead Sciences, Inc. Company Details
7.5.2 Gilead Sciences, Inc. Business Overview
7.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
7.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.5.5 Gilead Sciences, Inc. Recent Development
7.6 Intercept Pharmaceuticals, Inc.
7.6.1 Intercept Pharmaceuticals, Inc. Company Details
7.6.2 Intercept Pharmaceuticals, Inc. Business Overview
7.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
7.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.6.5 Intercept Pharmaceuticals, Inc. Recent Development
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Details
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
7.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022)
7.7.5 Zydus Cadila Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
